Some other genes, like CHEK2, ATM, PALB2, and BRIP1, show a modest tendency for BC; however, patients with these genes' mutations have 2–3 times the high risk of developing a malignant tumor (Chamseddine et al. 2022). This evidence concerns the gene PALB2 and breast cancer.